Effects of levosimendan on glutathione content in hepatocytes and LX-2.
- Elena Grossini (725160)
- Kevin Bellofatto (725161)
- Serena Farruggio (725162)
- Lorenzo Sigaudo (725163)
- Patrizia Marotta (725164)
- Giulia Raina (725165)
- Veronica De Giuli (725166)
- David Mary (725167)
- Piero Pollesello (725168)
- Rosalba Minisini (341216)
- Mario Pirisi (341217)
- Giovanni Vacca (725169)
Publication date
April 2015
DOIAbstract
<p>In A and B, b, c, e, f, g <i>P</i><0.05 vs a; c, d, e, f, g <i>P</i><0.05 vs b; d, e <i>P</i><0.05 vs c; d, f, g <i>P</i><0.05 vs e. In C and D, b, c, d <i>P</i><0.05 vs a; e <i>P</i><0.05 vs b. In D, e <i>P</i><0.05 vs c, d. GSH = glutathione. Other abbreviations are as in Figs <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0124742#pone.0124742.g001" target="_blank">1</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0124742#pone.0124742.g002" target="_blank">2</a>. The results obtained in hepatocytes and LX-2 are expressed as means of 5 or 4 independent experiments (%) ± SD (indicated by the bars), respectively.</p
Add to ORKG